1. CDC. State-specific mortality from sudden cardiac death – United States, 1999. MMWR Morb Mortal Wkly Rep 2002; 51: 123–126.
2. Cannom DS. Prevention of sudden cardiac death. J Cardiovasc Electrophysiol 2005; 16(Suppl): 21–27.
3. Cleland JG, Chattopadhyay S, Khand A et al. Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev 2002; 7: 229–242.
4. Bigger JT, Fleiss JL, Hieiger R et al. The Multicenter Post-Infarction Research Group: The relationships among ventricular tachyarrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250–258.
5. Maggioni AP, Zuanetti G, Franzosi MG et al. The GISSI-2 Investigators: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: The GISSI-2 results. Circulation 1993; 87: 312–322.
6. Moss AJ, Hall WJ, Cannom DS et al. The Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940.
7. Buxton AE, Lee KL, Fisher JD et al. The Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882–1890.
8. Lander P, Berbari EJ. Principles and signal processing techniques of the high-resolution electrocardiogram. Prog Cardiovasc Dis 1992; 35: 169–188.
9. Lander P, Berbari EJ, Rajagopalan CV et al. Critical analysis of the signal-averaged electrocardiogram: Improved identification of late potentials. Circulation 1993; 87: 105–117.
10. Steinberg JS, Berbari EJ. The signal-averaged electrocardiogram: Update on clinical applications. J Cardiovasc Electrophysiol 1996; 7: 972–988.
11. Breithardt G, Cain ME, El-Sherif N et al. Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology the American Heart Association and the American College of Cardiology. Circulation 1991; 83: 1481–1488.
12. Cain ME, Ahderson JL, Arnsdorf MF et al. American College of Cardiology Expert Consensus Document: Signal-Averaged Electrocardiography. J Am Coll Cardiol 1996; 27: 238–249.
13. Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991; 68: 751–755.
14. Guidera SA, Steinberg JS. The signal-averaged P-wave duration: A rapid non-invasive marker of risk for atrial fibrillation. J Am Coll Cardiol 1993; 21: 1645–1651.
15. Hiraki T, Ikeda H, Ohga M et al. Frequency and time domain analysis of P-wave in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998; 21: 56–64.
16. Yamada T, Fukunami M, Shimonagat T et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol 2000; 35: 405–413.
17. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473–1482.
18. El-Sherif N, Denes P, Katz R et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the post infarction period. J Am Coll Cardiol 1995; 25: 908–914.
19. Parer WJ, Parer JT, Holbrook RH et al. Validity of mathematical methods of quantitating fetal heart rate variability. Am J Obstet Gynecol 1985; 153: 402–409.
20. Akselrod S, Gordon D, Madwed JB et al. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol 1985; 249: 867–875.
21. Odemuyiwa O, Malik M, Farrell T et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991; 68: 434–439.
22. Farrell TG, Bashir Y, Cripps T et al. Risk stratification for arrhythmic events in post infarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18: 687–697.
23. Singer DH, Martin GJ, Magid N et al. Low heart rate variability and sudden cardiac death. J Electrocardiol 1988; 21(Suppl): 46–55.
24. Penaz J. Mayer waves: history and methodology. Automedica 1978; 2: 135–141.
25. Luczak H, Laurig W. An analysis of heart rate variability. Ergonomics 1973; 16: 85–97.
26. Malliani A, Pagani M, Lombardi F et al. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482–492.
27. Appel ML, Berger RD, Saul JP et al. Beat to beat variability in cardiovascular variables: Noise or music?
J Am Coll Cardiol 1989; 14: 1139–1148.
28. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165–1170.
29. Kleiger RE, Miller JP, Bigger JT et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256–262.
30. Zuanetti G, Neilson JMM, Latini R et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. Circulation 1996; 94: 432–436.
31. Malik M, Camm AJ, Janse MT et al. Depressed heart rate variability identifies post infarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263–1275.
32. Tapanainen JM, Thomsen PE, Kober L et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 2002; 90: 347–352.
33. Redwood S, Odemuyiwa O, Hnatkova K et al. Selection of dichotomy limits for multifactorial prediction of arrhythmic events and mortality in survivors of acute myocardial infarction. Eur Heart J 1997; 18: 1278–1287.
34. Hartikainen JEK, Malik M, Staunton A et al. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996; 28: 296–304.
35. Schmidt G, Malik M, Barthel P et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353: 1390–1396.
36. Grimm W, Schmidt G, Maisch B et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 2003; 14: 819–824.
37. Kautzner J, Hartikainen JE, Camm AJ et al. Arterial baroreflex sensitivity assessed from phase IV of the Valsalva maneuver. Am J Cardiol 1996; 78: 575–579.
38. Wichterle D, Melenovsky V, Necasova L et al. Stability of the non-invasive baroreflex sensitivity assessment using cross-spectral analysis of heart rate and arterial blood pressure variabilities. Clin Cardiol 2000; 23: 201–204.
39. La Rovere MT, Pinna GD, Hohnloser SH et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 2001; 103: 2072–2077.
40. La Rovere MT, Pinna GD, Mortara A. Assessment of baroreflex sensitivity. In: Malik M (ed). Clinical Guide to Cardiac Autonomic Tests. Dordrech: Kluwer Academic Publishers 1998: 257–281.
41. Mortara A, La Rovere MT, Pinna GD et al. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450–3458.
42. La Rovere MT, Bigger JT Jr, Marcus FI et al. The ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators: Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478–484.
43. Hohnloser SH, Klingenheben T, Yi-Gang Li et al. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: Prospectivecomparison with conventional risk markers. J Cardiovasc Electrophysiol 1998; 9: 1258–1268.
44. Waktare JEP. Current status and developments in cardiac event recorders. Card Electrophysiol Rev 1999; 3: 254–256.
45. Smith JM, Clancy E, Valeri C et al. Electrical alternans and cardiac electrical instability. Circulation 1988; 77: 110–121.
46. Verrier RL, Nearing BD, La Rovere MT. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic events. J Cardiovasc Electrophysiol 2003; 14: 705–711.
47. Weiss J, Garfinkel A, Karagueuzian HS et al. Chaos and the transition to ventricular fibrillation a new approach to anti-arrhythmic drug evaluation. Circulation 1999; 99: 2819–2826.
48. Pastore M, Girouard SD, Laurita KR et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999; 99: 1385–1394.
49. Zabel M, Mauss O, Lim K et al. Microvolt and macrovolt alternans of action potentials and the T wave in an isolated rabbit heart model [abstract]. Circulation 1998; 98: I10.
50. Banville I, Gray RA. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol 2002; 13: 1141–1149.
51. Cherry E, Fenton F. Suppression of alternans and conduction blocks despite steep APD restitution electronic, memory, and conduction velocity restitution effects. Am J Physiol Heart Circ Physiol 2004; 286: 2332–2341.
52. Hashimoto H, Suzuki K, Nakashima M. Effects of the ventricular premature beat on the alternation of the repolarization phase in ischemic myocardium during acute coronary occlusion in dogs. J Electrocardiol 1984; 17: 229–238.
53. Rubenstein DS, Lipsius SL. Premature beats elicit a phase reversal of mechanoelectrical alternans in cat ventricular myocytes. A possible mechanism for re-entrant arrhythmias. Circulation 1995; 91: 201–214.
54. Franz MR, Swerdlow CD, Liem LB et al. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988; 82: 972–979.
55. A. Karma, Spiral break-up in model equations of action potential propagation in cardiac tissue. Phys Rev Lett 1993; 71: 1103–1106.
56. Gehi AK, Stein RH, Metz LD et al. Microvolt T-wave alternans for risk stratification of ventricular tachyarrhythmic events a meta-analysis. J Am Coll Cardiol 2005; 46: 75–82.
57. Narayan SM, Smith JM et al. Exploiting rate hysteresis in repolarization alternans to optimize the sensitivity and specificity for ventricular tachycardia. J Am Coll Cardiol 2000; 35: 1485–1492.
58. Gold MR, Bloomfield DM, Anderson KP et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll
Cardiol 2000; 36: 2247–2253.
59. Rashba EJ, Osman AF, MacMurdy K et al. Exercise is superior to pacing for the measurement of T-wave alternans. J Cardiovasc Electrophysiol 2002; 13: 845–850.
60. Raatikainen M, Jokinen V, Virtanen V et al. Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol 2005; 28(Suppl 1): 193–197.
61. Murata M, Harada M, Shimizu A et al. Effect of long-term beta-blocker therapy on microvolt-level T-wave alternans in association with the improvement of the cardiac sympathetic nervous system and systolic function in patients with non-ischemic heart disease. Jpn Circ J 2003; 67: 821–825.
62. Kaufman ES, Mackall JA, Julka B et al. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am J Physiol Heart Circ Physiol 2000; 279: 1248–1255.
63. Kavesh NG, Shorofsky SR, Sarang SE et al. Effect of heart rate on T-wave alternans. J Cardiovasc Electrophysiol 1998; 9: 703–708.
64. Groh WJ, Shinn TS, Engelstein, EE et al. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 1999; 10: 1335–1339.
65. Hashimoto H, Nakashima M et al. Effects of calcium antagonists on the alternation of the ST-T complex and associated conduction abnormalities during coronary occlusion in dogs. Br J Pharmacol 1981; 74: 371–380.
66. Nearing BD, Huang AH, Verrier RL et al. Dynamic tracking of cardiac vulnerability by complex demodulation of the T-wave. Science 1991; 252: 437–440.
67. Bloomfield DM, Hohnloser SH, Cohen RJ et al. Interpretation and classification of microvolt T-wave alternans tests. J Cardiovasc Electrophysiol 2002; 13: 502–512.
68. Ikeda T, Sakata T, Takami M et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000; 35: 722–730.
69. Armoundas AA, Rosenbaum DS, Ruskin JN et al. Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiologic testing and arrhythmia-free survival. Heart 1998; 80: 251–256.
70. Klingenheben T, Zabel M, D’Agostino Sr RB et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure (letter). Lancet 2000; 356: 651–652.
71. Bloomfield DM, Steinman RC, Namerow PB et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004; 110: 1885–1889.
72. Grimm W, Christ M, Bach J et al. Non-invasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883–2891.
73. Tapanainen M, Still AM, Airaksinen KEJ et al. Prognostic significance of risk stratifiers of mortality, including T-wave alternans, after acute myocardial infarction results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001; 12: 645–652.
74. Wheelan K, Murkharji J, Rude RE et al. The MILIS Study Group. Sudden death and its relation to QT interval prolongation after myocardial infarction: Twoyear follow-up. Am J Cardiol 1986; 57: 745–750.
75. Puddu PE, Bourassa MG. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 1986; 19: 203–212.
76. Algra A, Tijssen JGP, Roelandt JRTC et al. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83: 1888–1894.
77. Katjalainen J, Reunanen A, Ristola P et al. QT interval as a cardiac risk factor in a middle aged population. Heart 1997; 77: 543–548.
78. Brendorp B, Elming H, Jun L et al. The DIAMOND Study Group: QTc Interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit most from antiarrhythmic treatment with dofetilide. Circulation 2001; 103: 1422–1427.
79. Ahnve A, Gilpin E, Madsen EB et al. Prognostic importance of QTc interval at discharge after acute myocardial infarction: A multicenter study of 865 patients. Am Heart J 1984; 108: 395–400.
80. De Bruyne MC, Hoes AW, Kors JA et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly: The Rotterdam study. Eur Heart J 1999; 20: 278–284.
81. Brooksby P, Batin PD, Nolan J et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure: The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK HEART). Eur Heart J 1999; 20: 1335–1341.
82. Goldberg RJ, Bengtson J, Chen Z et al. Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham Heart Study experience). Am J Cardiol 1991; 67: 55–58.
83. Lande G, Kyndt F, Baró I et al. Dynamic analysis of the QT interval in long QTl syndrome patients with a normal phenotype. Eur Heart J 2001; 22: 410–422.
84. Merri M, Moss AJ, Benhorin J et al. Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings: Findings in normal patients and patients with long QT syndrome. Circulation 1992; 85: 1816–1821.
85. Chevalier P, Burri H, Adeleine P et al. The Groupe d’Etude du Prognostic de 1’Infarctus du Myocarde (GREPI): QT dynamicity and sudden death after myocardial infarction: Results of a long-term follow-up study. J Cardiovasc Electrophysiol 2003; 14: 227–233.
86. Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342–344.
87. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995; 25: 746–752.
88. De Bruyne MC, Hoes AW, Kors JA et al. QTc dispersion predicts cardiac mortality in the elderly: The Rotterdam study. Circulation 1998; 97: 467–472.
89. Padmanabhan S, Silvet H, Amin J et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of < or = 40%. Am Heart J 2003; 145: 132–138.
90. Fu GS, Meissner A, Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur Heart J 1997; 18: 281–289.
91. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749–1766.
92. Glancy JM, Garrat CJ, Woods KL et al. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945–948.
93. Spargias KS, Lindsay SJ, Kawar GI et al. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J 1999; 20: 1158–1165.
94. Milletich A, Latini R, Garrido G et al. The GISSI-ECG Collaborative Group. Lack of prognostic value of QT dispersion at discharge in patients recovering from acute myocardial infarction: A case control studyfrom GISSI database. Eur Heart J 1996; 17: 30. Abstract.
95. Zabel M, Klingenheben T, Franz MR et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction. Circulation 1998; 97: 2543–2550.
96. Cooper MJ, Koo CC, Skinner MP et al. Comparison of immediate versus day-to-day variability of ventricular tachycardia induction by programmed stimulation. J Am Coll Cardiol 1989; 13: 1599–1607.
97. Wellens HJ, Brugada P, Stevenson WG. Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: What is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985; 72: 1–7.
98. Buxton AE, Josephson ME, Marchlinski FE et al. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. J Am Coll Cardiol 1993; 21: 90–98.
99. Kowey PR, Taylor JE, Marinchak RA et al. Does programmed stimulation really help in the evaluation of patients with non-sustained ventricular tachycardia? Results of a meta-analysis. Am Heart J 1992; 123: 481–485.
100. Wilber DJ, Olshansky B, Moran JF et al. Electrophysiological testing and non-sustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990; 82: 350–358.
101. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.
102. Moss AJ. Dead is dead, but can we identify patients at increased risk for sudden cardiac death? J Am Coll Cardiol 2003; 42: 659–660.
103. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic- drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583.
104. Connolly SJ, Gent M, Roberts RS et al. Canadian Implantable Defibrillator Study (CIDS): Randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1287–1302.
105. Kuck KH, Cappato R, Siebels J et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748–754.
106. Maron BJ, Gohman TE, Kyle SB et al. Clinical profile and spectrum of commotio cordis. JAMA 2002; 287: 1142–1146.
107. Mittal S, Iwai S, Stein KM et al. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999; 34: 1082–1089.
108. Zipes DP, Wellen HJJ. Sudden cardiac death. Circulation 1998; 98: 2334–2351.
109. Poole JE, Bardy GH. Sudden cardiac death. In: Zipes DP, Jalife F (eds). Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders 2000: 615–640.
110. Berbari EJ, Lazzara R. Cardiac Electrophysiology. In: Zipes DP. From Cell to Bedside. 4th ed. Philadelphia: WB Saunders 2004: 795.
111. Cohen RJ. Cardiac Electrophysiology. In: Zipes DP. From Cell to Bedside. 4th ed. Philadelphia: WB Saunders 2004: 841.